Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When T cells get old.

Graham Pawelec1

  • 1Center for Medical Research, University of Tuebingen, D-72072 Tuebingen, Germany. graham.pawelec@uni-tuebingen.de

Science of Aging Knowledge Environment : SAGE KE
|December 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing fourteen consensus biomarkers of aging: epigenetic pace of aging as the strongest predictor of mortality in BASE-II.

Biomarker research·2026
Same author

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Journal for immunotherapy of cancer·2026
Same author

Aging-associated immune signature as a predictor of mortality in end-stage renal disease: results from the longitudinal iESRD study.

Immunity & ageing : I & A·2025
Same author

Open problems in ageing science: a roadmap for biogerontology.

GeroScience·2025
Same author

Clinical data-driven classification of pre-frailty reveals sex-specific patterns - Data from the Berlin Aging Study II (BASE-II).

Mechanisms of ageing and development·2025
Same author

Nonuniversality of inflammaging across human populations.

Nature aging·2025
Same journal

I come not to bury SAGE KE but to appraise It.

Science of aging knowledge environment : SAGE KE·2006
Same journal

Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment.

Science of aging knowledge environment : SAGE KE·2006
Same journal

From bedside to bench: does mental and physical activity promote cognitive vitality in late life?

Science of aging knowledge environment : SAGE KE·2006
Same journal

The unusual genetics of human longevity.

Science of aging knowledge environment : SAGE KE·2006
Same journal

A work in progress: the metabolic syndrome.

Science of aging knowledge environment : SAGE KE·2006
Same journal

WRN's tenth anniversary.

Science of aging knowledge environment : SAGE KE·2006
See all related articles

Vaccination effectiveness decreases in older adults due to immunosenescence, the decline in immune system performance. Understanding these age-related immune changes is key to improving vaccines for the elderly.

Area of Science:

  • Gerontology
  • Immunology
  • Vaccinology

Background:

  • Infectious diseases pose a greater threat to older adults.
  • Vaccine efficacy is notably reduced in the elderly population.
  • Age-related immune decline, termed immunosenescence, underlies these challenges.

Purpose of the Study:

  • To explore the reasons behind reduced vaccine effectiveness in older individuals.
  • To investigate the mechanisms of immunosenescence.
  • To identify strategies for enhancing vaccination efficacy in the elderly.

Main Methods:

  • Summary of presentations from a recent workshop.
  • Discussion of age-related changes in immune system components.
  • Analysis of factors contributing to disrupted immune performance.

Related Experiment Videos

Main Results:

  • Immunosenescence is identified as the primary cause of diminished vaccine response in the elderly.
  • Multiple components of the immune system are affected by aging.
  • Insights into improving vaccination strategies were discussed.

Conclusions:

  • Age-related immune system changes significantly impact vaccine effectiveness.
  • Further research into immunosenescence is crucial for developing better vaccines for older adults.
  • Targeted strategies are needed to bolster immune responses to vaccination in the elderly.